You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemoglobinuria

Showing 1 - 25 of 316
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

Available
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Aug 31, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (HRS-5965 tablets)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • HRS-5965 tablets
  • (no location specified)
Sep 20, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Kyiv (OMS906 study drug)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • OMS906 study drug
  • Kyiv, Ukraine
    Omeros Investigational Site
May 25, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Bloemfontein, Cape Town, Pretoria (BCX10013)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Bloemfontein, South Africa
  • +2 more
Oct 20, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial (MY008211A tablets)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • MY008211A tablets
  • (no location specified)
Nov 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Tianjin (MY008211A tablets)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • MY008211A tablets
  • Tianjin, Tianjin, China
    Nstitute of Hematology & Blood Disease Hospital, Chinese Academy
Sep 17, 2023

Pegcetacoplan in Paroxysmal Nocturnal Hemoglobinuria (PNH)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Mar 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Beijing, China
  • +6 more
May 24, 2023

PNH - Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

Not yet recruiting
  • PNH - Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Feb 13, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Budapest, Ampang (BCX9930)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Budapest, Hungary
  • +1 more
Feb 14, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • (no location specified)
Jan 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Treated With Anti-C5

Completed
  • Paroxysmal Nocturnal Hemoglobinuria
  • Anti-C5 antibody treatment
  • Paris, France
    AP-HP Hôpital Saint Louis
Apr 24, 2023

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Brisbane (ADX-038, Placebo)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Brisbane, Queensland, Australia
    Nucleus Network Brisbane
May 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial run by the Aplastic Anemia and MDS International Foundation

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
    • Bethesda, Maryland
      Aplastic Anemia and MDS International Foundation
    Feb 23, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial (Pozelimab, Cemdisiran)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Feb 22, 2023

    Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (OMS906 Study Drug - 3 mg/kg, OMS906 Study Drug - 5 mg/kg, Ravulizumab)

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • OMS906 Study Drug - 3 mg/kg
    • +2 more
    • Aachen, Germany
    • +4 more
    Jul 25, 2023

    Paroxysmal Nocturnal Hemoglobinuria, PNH, Extravascular Hemolysis Trial (Danicopan)

    Available
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • (no location specified)
    Aug 1, 2023

    Pharmacodynamics of Eculizumab in Paroxysmal Nocturnal

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • Blood collection for measurement of eculizumab peak concentrations
    • Nijmegen, Netherlands
      Radboudumc
    Aug 23, 2022

    Paroxysmal Nocturnal Hemoglobinuria Trial (NM8074, Soliris)

    Not yet recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • (no location specified)
    Jan 17, 2023

    Adult Paroxysmal Nocturnal Hemoglobinuria of High-risk Hemolysis

    Completed
    • Paroxysmal Nocturnal Hemoglobinuria, Natural History Study
      • Beijing, China
        Peking Union Medical College Hospital
      Jun 30, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial (Iptacopan)

      Not yet recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • (no location specified)
      Nov 18, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Worldwide (Ravulizumab)

      Active, not recruiting
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria
      • Ravulizumab
      • Atlanta, Georgia
      • +8 more
      Aug 15, 2022

      Ravulizumab in Italian Paroxysmal Nocturnal Hemoglobinuria

      Recruiting
      • Paroxysmal Nocturnal Hemoglobinuria
      • Brescia, Italy
      • +5 more
      Jul 13, 2022

      Paroxysmal Nocturnal Hemoglobinuria Trial in Changsha (MY008211A tablets)

      Completed
      • Paroxysmal Nocturnal Hemoglobinuria
      • MY008211A tablets
      • Changsha, Hunan, China
        The Third Hospital of Changsha
      Apr 13, 2023

      Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)

      Active, not recruiting
      Has Results
      • Paroxysmal Nocturnal Hemoglobinuria (PNH)
      • Baltimore, Maryland
      • +4 more
      Aug 15, 2022